161 related articles for article (PubMed ID: 22149278)
1. A monoclonal antibody against the oncogenic mucin 1 cytoplasmic domain.
Panchamoorthy G; Rehan H; Kharbanda A; Ahmad R; Kufe D
Hybridoma (Larchmt); 2011 Dec; 30(6):531-5. PubMed ID: 22149278
[TBL] [Abstract][Full Text] [Related]
2. Characterization of an anti-MUC1 monoclonal antibody with potential as a cancer vaccine.
Qi W; Schultes BC; Liu D; Kuzma M; Decker W; Madiyalakan R
Hybrid Hybridomics; 2001; 20(5-6):313-24. PubMed ID: 11839249
[TBL] [Abstract][Full Text] [Related]
3. Evolution of the human MUC1 oncoprotein.
Duraisamy S; Kufe T; Ramasamy S; Kufe D
Int J Oncol; 2007 Sep; 31(3):671-7. PubMed ID: 17671696
[TBL] [Abstract][Full Text] [Related]
4. Epitope mapping of PR81 anti-MUC1 monoclonal antibody following PEPSCAN and phage display techniques.
Mohammadi M; Rasaee MJ; Rajabibazl M; Paknejad M; Zare M; Mohammadzadeh S
Hybridoma (Larchmt); 2007 Aug; 26(4):223-30. PubMed ID: 17725384
[TBL] [Abstract][Full Text] [Related]
5. A Mucin1 C-terminal Subunit-directed Monoclonal Antibody Targets Overexpressed Mucin1 in Breast Cancer.
Wu G; Kim D; Kim JN; Park S; Maharjan S; Koh H; Moon K; Lee Y; Kwon HJ
Theranostics; 2018; 8(1):78-91. PubMed ID: 29290794
[No Abstract] [Full Text] [Related]
6. A novel protein derived from the MUC1 gene by alternative splicing and frameshifting.
Levitin F; Baruch A; Weiss M; Stiegman K; Hartmann ML; Yoeli-Lerner M; Ziv R; Zrihan-Licht S; Shina S; Gat A; Lifschitz B; Simha M; Stadler Y; Cholostoy A; Gil B; Greaves D; Keydar I; Zaretsky J; Smorodinsky N; Wreschner DH
J Biol Chem; 2005 Mar; 280(11):10655-63. PubMed ID: 15623537
[TBL] [Abstract][Full Text] [Related]
7. Epitope mapping of anti-MUC1 mucin protein core monoclonal antibodies.
Petrakou E; Murray A; Price MR
Tumour Biol; 1998; 19 Suppl 1():21-9. PubMed ID: 9422085
[TBL] [Abstract][Full Text] [Related]
8. Structure/activity studies of the anti-MUC1 monoclonal antibody C595 and synthetic MUC1 mucin-core-related peptides and glycopeptides.
Spencer DI; Missailidis S; Denton G; Murray A; Brady K; Matteis CI; Searle MS; Tendler SJ; Price MR
Biospectroscopy; 1999; 5(2):79-91. PubMed ID: 10217327
[TBL] [Abstract][Full Text] [Related]
9. MUC1/X protein immunization enhances cDNA immunization in generating anti-MUC1 alpha/beta junction antibodies that target malignant cells.
Rubinstein DB; Karmely M; Ziv R; Benhar I; Leitner O; Baron S; Katz BZ; Wreschner DH
Cancer Res; 2006 Dec; 66(23):11247-53. PubMed ID: 17145869
[TBL] [Abstract][Full Text] [Related]
10. Mouse mucin 1 (MUC1) defined by monoclonal antibodies.
Xing PX; Lees C; Lodding J; Prenzoska J; Poulos G; Sandrin M; Gendler S; McKenzie IF
Int J Cancer; 1998 Jun; 76(6):875-83. PubMed ID: 9626356
[TBL] [Abstract][Full Text] [Related]
11. Targeting the human MUC1-C oncoprotein with an antibody-drug conjugate.
Panchamoorthy G; Jin C; Raina D; Bharti A; Yamamoto M; Adeebge D; Zhao Q; Bronson R; Jiang S; Li L; Suzuki Y; Tagde A; Ghoroghchian PP; Wong KK; Kharbanda S; Kufe D
JCI Insight; 2018 Jun; 3(12):. PubMed ID: 29925694
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of a novel monoclonal antibody against tumor-associated MUC1 for diagnosis and prognosis of breast cancer.
Stergiou N; Nagel J; Pektor S; Heimes AS; Jäkel J; Brenner W; Schmidt M; Miederer M; Kunz H; Roesch F; Schmitt E
Int J Med Sci; 2019; 16(9):1188-1198. PubMed ID: 31588183
[TBL] [Abstract][Full Text] [Related]
13. MUC1 isoform specific monoclonal antibody 6E6/2 detects preferential expression of the novel MUC1/Y protein in breast and ovarian cancer.
Hartman M; Baruch A; Ron I; Aderet Y; Yoeli M; Sagi-Assif O; Greenstein S; Stadler Y; Weiss M; Harness E; Yaakubovits M; Keydar I; Smorodinsky NI; Wreschner DH
Int J Cancer; 1999 Jul; 82(2):256-67. PubMed ID: 10389761
[TBL] [Abstract][Full Text] [Related]
14. Characterization of the MUC1-C Cytoplasmic Domain as a Cancer Target.
Raina D; Agarwal P; Lee J; Bharti A; McKnight CJ; Sharma P; Kharbanda S; Kufe D
PLoS One; 2015; 10(8):e0135156. PubMed ID: 26267657
[TBL] [Abstract][Full Text] [Related]
15. A novel anti-MUC1 antibody against the MUC1 cytoplasmic tail domain: use in sensitive identification of poorly differentiated cells in adenocarcinoma of the stomach.
Yonezawa S; Kitajima S; Higashi M; Osako M; Horinouchi M; Yokoyama S; Kitamoto S; Yamada N; Tamura Y; Shimizu T; Tabata M; Goto M
Gastric Cancer; 2012 Oct; 15(4):370-81. PubMed ID: 22237656
[TBL] [Abstract][Full Text] [Related]
16. Human single-chain Fv antibodies to MUC1 core peptide selected from phage display libraries recognize unique epitopes and predominantly bind adenocarcinoma.
Henderikx P; Kandilogiannaki M; Petrarca C; von Mensdorff-Pouilly S; Hilgers JH; Krambovitis E; Arends JW; Hoogenboom HR
Cancer Res; 1998 Oct; 58(19):4324-32. PubMed ID: 9766660
[TBL] [Abstract][Full Text] [Related]
17. Staining of MUC1 in ovarian cancer tissues with PankoMab-GEX detecting the tumour-associated epitope, TA-MUC1, as compared to antibodies HMFG-1 and 115D8.
Dian D; Lenhard M; Mayr D; Heublein S; Karsten U; Goletz S; Kuhn C; Wiest I; Friese K; Weissenbacher T; Jeschke U
Histol Histopathol; 2013 Feb; 28(2):239-44. PubMed ID: 23275306
[TBL] [Abstract][Full Text] [Related]
18. Cell surface-associated anti-MUC1-derived signal peptide antibodies: implications for cancer diagnostics and therapy.
Kovjazin R; Horn G; Smorodinsky NI; Shapira MY; Carmon L
PLoS One; 2014; 9(1):e85400. PubMed ID: 24416403
[TBL] [Abstract][Full Text] [Related]
19. An essential epitope of anti-MUC1 monoclonal antibody KL-6 revealed by focused glycopeptide library.
Ohyabu N; Hinou H; Matsushita T; Izumi R; Shimizu H; Kawamoto K; Numata Y; Togame H; Takemoto H; Kondo H; Nishimura S
J Am Chem Soc; 2009 Dec; 131(47):17102-9. PubMed ID: 19899793
[TBL] [Abstract][Full Text] [Related]
20. Purification of monoclonal antibodies by epitope and mimotope affinity chromatography.
Murray A; Sekowski M; Spencer DI; Denton G; Price MR
J Chromatogr A; 1997 Oct; 782(1):49-54. PubMed ID: 9368405
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
